Oral PCSK9 to drop LDL levels low

Published On 2021-12-06 12:20 GMT | Update On 2021-12-06 12:20 GMT

Low-density lipoprotein (LDL) cholesterol, popularly known as bad cholesterol is major cause of heart disease. LDL C causes build-up of fatty deposits within arteries, reducing or blocking blood flow thereby causing ischemic strokes and heart attacks. PCSK9 inhibitors work by a mechanism of blocking a liver protein that helps to destroy LDL cholesterol receptors on the surface of cells.

The PCSK9 protein is an important regulator of circulating LDL‐C levels, through its inhibitory action on recycling of the LDL receptor (LDLR). PCSK9 inhibition thus offers a novel therapeutic mechanism for the lowering of LDL‐C levels.

For more details, check out the full story on the link below:

Oral PCSK9 Inhibitor May Significantly Reduce LDL C Levels: DALLAS, The First Human Trial

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Oral PCSK9 to drop LDL levels low

Similar News

Study Reveals Poor Early Heart Health Increases Lifetime CVD Risk 10-Fold

Cardiovascular Complications Now Affect 1 in 7 Pregnancies: AHA Study Suggests

SMFM Releases New Guidelines for Managing Heart Failure in Pregnancy and Postpartum

Yoga vs. Exercise: Study Reveals Which One Really Boosts Vascular Health?

Fitter Hearts Beat Less, Live Longer: New Study Debunks Exercise Myth

What's Putting India at Risk for Diabetes and Obesity? ICMR Study Reveals the Hidden Dietary Culprit

Do Heart Attacks Really Strike Without Warning, or Are We Just Missing Signs? Study Sheds Light

Study Finds Exercise Rewires Left and Right Heart Nerves in Distinct Ways